Perbedaan Diagnos Laboratorium Utama Tbk. dan Morenzo Abadi Perkasa Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Morenzo Abadi Perkasa Tbk. diperdagangkan di Rp69 (kapitalisasi pasar 147,05 M, volume 24 jam 8,6 jt). Perbedaan utamanya: Diagnos Laboratorium Utama Tbk. jauh lebih besar — sekitar 2,1× kapitalisasi pasar Morenzo Abadi Perkasa Tbk., dan Morenzo Abadi Perkasa Tbk. lebih aktif diperdagangkan (8,6 jt vs 963,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | ENZO | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 147,05 M |
Volume | 963,6 rb | 8,6 jt |
Lot | 9,64 rb | 85,96 rb |
Perputaran | 217,67 jt | 591,25 jt |
Harga Rata-rata | 225,89 | 68,78 |
Nilai Transaksi | 217,67 jt | 591,25 jt |
Harga Ekuilibrium Indikatif | 226 | 69 |
Volume Ekuilibrium Indikatif | 1 rb | 4,14 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.
Selengkapnya di halaman ENZO →